🟢 Intervacc is trading 4.27% up today despite lower sales and wider operating loss

Intervacc is trading 4.27% up at €0.08, with no clear company-specific catalyst identified for the August 21, 2026 move.

• Its January–June 2026 interim report, released August 20, showed lower sales and a wider operating loss.
• Coverage characterized the report as having few surprises.
• Broader biotech sentiment was weak; trading activity and volume details were unavailable.